Rocket Lab Braces for Q1 Earnings Amid Soaring Expectations
MarketBeat· 2025-05-05 11:38
Rocket Lab USA TodayRKLBRocket Lab USA$22.99 +0.87 (+3.93%) 52-Week Range$3.66▼$33.34Price Target$23.25Add to WatchlistRocket Lab USA NASDAQ: RKLB, a rising force in the aerospace sector, is set to report its first-quarter 2025 earnings on May 8. This earnings release is shaping to be one of the company’s most pivotal, with expectations running high amid growing momentum in government contracts and space systems. The sentiment heading of the report is fairly mixed. While analyst ratings remain broadly bull ...
TC Energy's Q1 Earnings Miss Estimates, Revenues Decline Y/Y
ZACKS· 2025-05-05 11:35
TC Energy Corporation (TRP) reported first-quarter 2025 adjusted earnings of 66 cents per share, which missed the Zacks Consensus Estimate of 70 cents. Moreover, the bottom line decreased from 92 cents in the year-ago period. This underperformance could be attributed to weak Power and Energy Solutions segment results. (See the Zacks Earnings Calendar to stay ahead of market-making news.)This energy infrastructure provider's quarterly revenues of $2.5 billion also missed the Zacks Consensus Estimate by $18 m ...
Wall Street Analysts Like These AI Stocks in 2025. Should You Buy Them?
The Motley Fool· 2025-05-05 11:35
In a year of uncertainty for the economy, leading companies in artificial intelligence (AI) are standing out. Wall Street analysts recently made bullish calls on Broadcom (AVGO 3.17%) and ServiceNow (NOW 2.00%).One thing that stands out at first glance with these stocks is their expensive valuations. Both stocks trade at high multiples of their earnings and cash flow that could limit near-term upside. Let's see why these stocks may or may not justify their premiums. 1. BroadcomBroadcom supplies essential n ...
Tesla's Affordable EV: Do the Latest Details Make the Stock a Buy?
The Motley Fool· 2025-05-05 11:35
Tesla (TSLA 2.41%) has been talking about a cheaper EV for years, but it has always been just out of reach, and plans to build one have continually changed. But the company recently gave some updates about its progress on releasing a more affordable EV, even if details are still sparse.Here are three things we know about Tesla's upcoming lower-priced EV and what it may mean for the company after it is launched. 1. The new model could just be a stripped-down version of a current modelLast year, Tesla reporte ...
Seeking +16% Yields During Uncertain Times: Dynex Capital
Seeking Alpha· 2025-05-05 11:35
Save yourself thousands of dollars by creating a portfolio that pays you to hold it. No selling required to fund your retirement dreams. Tired of going it alone or visiting a financial advisor who just doesn't seem to care? Join our lively group! Our Income Method generates strong returns, making retirement investing less stressful and straightforward .Features include: model portfolio with buy/sell alerts, preferred and baby bond portfolios for more conservative investors, vibrant and active chat with acce ...
Hazer and KBR Enter Global Deal to Accelerate Licensing and Commercialisation
GlobeNewswire· 2025-05-05 11:35
Highlights Binding strategic alliance with KBR (NYSE: KBR), a world-leading engineering group and global technology licensor set to supercharge Hazer’s commercialisation strategyHazer is KBR’s exclusive partner for marketing and licensing of methane pyrolysis technologyClear revenue visibility targeting multiple license deals within 6 years, materially derisking Hazer’s businessplan Capital-lite licensing model maintained; KBR A$3million work program contribution preserves Hazer’s robust funding positionStr ...
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
GlobeNewswire· 2025-05-05 11:35
– Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA – MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATH434 for the treatment of Multiple S ...
Exxon Mobil: Totally Undervalued
Seeking Alpha· 2025-05-05 11:30
ExxonMobil (NYSE: XOM )’s first fiscal quarter earnings were better-than-expected with the oil and gas company beating expectations, despite downward pressure on petroleum prices throughout the quarter. The energy company saw solid gainsAnalyst’s Disclosure: I/we have a beneficial long position in the shares of XOM, CVX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking ...
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
Benzinga· 2025-05-05 11:30
U.S. stocks settled higher on Friday following the release of jobs data, with the S&P 500 recording gains for the ninth consecutive day to notch its longest winning streak since Nov. 2004.All three major averages recorded gains for the second week, with the S&P 500 adding 2.9% and the Dow gaining 3% on the week. The Nasdaq, meanwhile, closed higher by 3.4% for the week.Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track ...
Lamar Advertising Acquires Premier Outdoor Media
Prnewswire· 2025-05-05 11:30
MOUNT LAUREL, N.J., May 5, 2025 /PRNewswire/ -- Premier Outdoor Media ("Premier" or the "Company"), a leading independent operator of out-of-home advertising ("OOH") assets throughout the Northeast Corridor, announced today that it has divested its OOH assets to Lamar Advertising Company (NASDAQ: LAMR) ("Lamar"). Financial terms of the transaction were not disclosed.Premier was founded in 2018 through Caruth Capital Partners, LLC's ("Caruth") acquisition of Jersey Premier Outdoor Media, LLC, in partnership ...